BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2014 10:47:00 AM | Browse: 1281 | Download: 1966
 |
Received |
|
2014-05-15 20:18 |
|
Peer-Review Started |
|
2014-05-16 21:37 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-06-20 20:30 |
|
Revised |
|
2014-07-08 15:54 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-08-28 10:00 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-08-28 10:35 |
|
Articles in Press |
|
2014-08-28 10:57 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-11-16 18:19 |
|
Publish the Manuscript Online |
|
2014-12-02 10:46 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Recent applications of chemosensitivity tests for colorectal cancer treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yong Sik Yoon and Jin Cheon Kim |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Asan Institute for Life Sciences |
2014-69 |
| National Research Foundation |
NRF-2013R1A2A1A03070986 |
| Ministry of Science, ICT, and Future Planning, the Korea Health 21 RD Project |
HI06C0868 |
| Ministry of Science, ICT, and Future Planning, the Korea Health 21 RD Project |
HI13C1750 |
| Center for Development and Commercialization of Anti-Cancer Therapeutics |
HI10C2014 |
|
| Corresponding Author |
Jin Cheon Kim, MD, PhD, Department of Surgery, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul 138-736, South Korea. jckim@amc.seoul.kr |
| Key Words |
Colorectal adenocarcinomas; Colorectal cancer; Chemotherapy; In vitro assays; Molecular targeted therapy; Individualized therapy |
| Core Tip |
This review summarizes currently available predictive and prognostic chemosensitivity tests and biomarkers in terms of cell culture, protein, and gene. Cell culture-based chemosensitivity tests are used widely in clinical practice because of their short assay period, technical simplicity, and the requirement of small amount of specimen. Among protein- and gene-based chemosensitivity assays, assessment of KRAS mutation status predicts the response to epidermal growth factor receptor-targeted therapy in colorectal cancer patients. |
| Publish Date |
2014-12-02 10:46 |
| Citation |
Yoon YS, Kim JC. Recent applications of chemosensitivity tests for colorectal cancer treatment. World J Gastroenterol 2014; 20(44): 16398-16408
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i44/16398.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i44.16398 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
